Abstract No. 193 Protective Factors in Developing Symptoms of Pelvic Venous Disorders): Evaluation of Asymptomatic Patients with Pelvic Varices

This study aimed to explore whether specific pharmacologic exposure, namely neurokinin-1 (NK1) receptor antagonists, calcitonin gene-related peptide (CGRP) receptor antagonists, and the nitric oxide (NO) release antagonist medroxyprogesterone, could serve as protective factors against PeVD symptom development.

Source: Journal of Vascular and Interventional Radiology : JVIR - February 21, 2024 Category: Radiology Authors: E. Gonzales, V. Risner, J. Du Pisanie, N. Keefe, P. Mody, G. Salazar Source Type: research